Results 141 to 150 of about 9,116 (165)

Neonatal side effects of maternal labetalol treatment in severe preeclampsia

Early Human Development, 2012
Objective: Labetalol is often used in severe preeclampsia (PE). Hypotension, bradycardia and hypoglycemia are feared neonatal side effects, but may also occur in (preterm) infants regardless of labetalol exposure.
Teelkien R van Veen, Christian V Hulzebos, Karst Y Heida   +2 more
exaly   +2 more sources

Safety of high-dose intravenous labetalol in hypertensive crisis

American Journal of Health-System Pharmacy, 2019
Purpose: The study assesses the safety of high-dose intravenous (i.v.) labetalol in adults. Methods: This is a retrospective administrative record review of 28 hospitals in one health care system, from October 2010 through October 2015.
Jason Hecht
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

The Low/High BCS Permeability Class Boundary: Physicochemical Comparison of Metoprolol and Labetalol

Molecular Pharmaceutics, 2014
Arik Dahan, Gordon L. Amidon, Moran Zur
exaly  

Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy

Hypertension, 2017
Lucy Chappell, Paul Seed, Kennedy Cruickshank   +2 more
exaly  

Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in Pregnancy

Clinical Pharmacokinetics, 2013
Hyunyoung Jeong, Sarah J Kilpatrick, James H Fischer   +2 more
exaly